PARIS, July 11, 2016 -- Following some information related to sale talks that Ipsos would have with a number of private equity firms, LT Participations, the holding company of Ipsos, controlled by Mr. Didier Truchot, indicates that no talks are currently lead by Ipsos SA.
As far as LT Participations is concerned, it is periodically reviewing with its shareholders for patrimonial reasons mainly, indications of interest received spontaneously or at its request, without having entered necessarily in a formal sale process. In this context, no decision in relation with the evolution of its ownership structure has been taken and in order to avoid any misunderstanding, LT Participations has decided to stop any talk.
In any event, the strategy defined a long time ago and followed by Mr. Didier Truchot, founder and Chief Executive Officer of Ipsos remains unchanged: developing a leader in market and public opinion research, global, specialised and independent.
LT Participations - Press Release - 11 July 2016 http://hugin.info/143536/R/2027590/753570.pdf
HUG#2027590
CONTACT: Laurence Stoclet
Deputy CEO
+ 33 1 41 98 90 20
Antoine Lagoutte
President, Corporate Finance
+33 1 41 98 92 43


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



